John D. Schreier;Christopher D. Cox;Izzat T. Raheem
发明人:
Christopher D. Cox,Izzat T. Raheem,John D. Schreier
申请号：
US13816568
公开号：
US20130137707A1
申请日:
2011.09.26
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention is directed to pyrazolopyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
